Companies / BOC Sciences / Galcanezumab
BOC Sciences

Galcanezumab | BOC Sciences

Galcanezumab is a humanized monoclonal antibody that selectively binds to calcitonin gene-related peptide (CGRP). Galcanezumab has the potential for the preventive treatment of chronic migraine.

Reviews


No reviews yet

ABOUT THE COMPANY

BOC Sciences specializes in small molecule synthesis, biosynthesis, purification, and characterization. It provides a wide range of research chemicals and biochemicals, including inhibitors, building blocks, carbohydrates, nucleosides, nucleotides, GMP Products, impurities and metabolites, APIs, natural compounds, ADCs, stem cell molecules and chiral compounds.